Trial Profile
Prospective study investigating the effect of deferasirox as iron chelation therapy on bone marrow iron content in patients with iron overload
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Anaemia; Haemochromatosis; Iron overload; Thalassaemia
- Focus Therapeutic Use
- 03 Feb 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology